In recent years, oligonucleotide drugs have become the focus of research and development. They can be synthesized by solid phase synthesis instrument or liquid phase chemical methods. Therefore, it is possible to modify each single nucleotide to optimize its specificity, stability, pharmacokinetics and other aspects. IPHASE has a professional team and complete equipment to support the screening and development of oligonucleotide drugs.